STEVEN GROSSMAN 2/15/19 STEVEN GROSSMAN 2/15/19 Long Wait Is Over. FY 19 FDA Funding Will Be Set When the President Signs the Appropriations Bill Read More STEVEN GROSSMAN 2/14/19 STEVEN GROSSMAN 2/14/19 House-Senate Conferees Release Proposed Final Appropriations Bill Read More Analysis and Commentary STEVEN GROSSMAN 2/8/19 Analysis and Commentary STEVEN GROSSMAN 2/8/19 The Questions -- and the Answers -- Continue! Read More STEVEN GROSSMAN 2/8/19 STEVEN GROSSMAN 2/8/19 CR/Shutdown Countdown: One Week to Go Read More Analysis and Commentary STEVEN GROSSMAN 2/1/19 Analysis and Commentary STEVEN GROSSMAN 2/1/19 Members' Questions Are Still Flowing In Read More Advocacy at a Glance STEVEN GROSSMAN 2/1/19 Advocacy at a Glance STEVEN GROSSMAN 2/1/19 February 15 Is the New Deadline; Negotiations Begin Read More Analysis and Commentary STEVEN GROSSMAN 1/26/19 Analysis and Commentary STEVEN GROSSMAN 1/26/19 Shutdown- and BA-Related Q&As Continued Read More Advocacy at a Glance STEVEN GROSSMAN 1/26/19 Advocacy at a Glance STEVEN GROSSMAN 1/26/19 Possible Temporary End to Shutdown Announced. Read More STEVEN GROSSMAN 1/18/19 STEVEN GROSSMAN 1/18/19 The Shutdown: Media Snippets and Commentary Read More Advocacy at a Glance STEVEN GROSSMAN 1/18/19 Advocacy at a Glance STEVEN GROSSMAN 1/18/19 Alliance Works to be a Leading Source of Concern on Shutdown Read More STEVEN GROSSMAN 1/11/19 STEVEN GROSSMAN 1/11/19 The Shutdown Continues: More Qs; More As Read More Advocacy at a Glance STEVEN GROSSMAN 1/11/19 Advocacy at a Glance STEVEN GROSSMAN 1/11/19 Deteriorating Situation at Shut-Down FDA, Despite Commissioner Gottlieb’s Best Efforts Read More STEVEN GROSSMAN 1/7/19 STEVEN GROSSMAN 1/7/19 Alliance Releases FDA Shutdown Toolkit Read More Analysis and Commentary STEVEN GROSSMAN 1/4/19 Analysis and Commentary STEVEN GROSSMAN 1/4/19 Can the Alliance Help to End the Shutdown? No and Yes! Read More Advocacy at a Glance STEVEN GROSSMAN 1/4/19 Advocacy at a Glance STEVEN GROSSMAN 1/4/19 Soon To Be Released: Alliance’s FDA Shutdown Toolkit Read More STEVEN GROSSMAN 12/21/18 STEVEN GROSSMAN 12/21/18 What Happens At and After Midnight, Cinderella? Read More Advocacy at a Glance STEVEN GROSSMAN 12/21/18 Advocacy at a Glance STEVEN GROSSMAN 12/21/18 Barring a Last-Minute Deal, A Partial FDA Shutdown is Likely Read More Analysis and Commentary STEVEN GROSSMAN 12/15/18 Analysis and Commentary STEVEN GROSSMAN 12/15/18 Is a Shutdown on the Horizon? Read More Analysis and Commentary STEVEN GROSSMAN 12/10/18 Analysis and Commentary STEVEN GROSSMAN 12/10/18 Critical Issues for the CVM Moving Forward Read More Advocacy at a Glance STEVEN GROSSMAN 12/10/18 Advocacy at a Glance STEVEN GROSSMAN 12/10/18 Two-Week CR Extension: Can It End the Impasse? Read More Newer Posts Older Posts
STEVEN GROSSMAN 2/15/19 STEVEN GROSSMAN 2/15/19 Long Wait Is Over. FY 19 FDA Funding Will Be Set When the President Signs the Appropriations Bill Read More
STEVEN GROSSMAN 2/14/19 STEVEN GROSSMAN 2/14/19 House-Senate Conferees Release Proposed Final Appropriations Bill Read More
Analysis and Commentary STEVEN GROSSMAN 2/8/19 Analysis and Commentary STEVEN GROSSMAN 2/8/19 The Questions -- and the Answers -- Continue! Read More
Analysis and Commentary STEVEN GROSSMAN 2/1/19 Analysis and Commentary STEVEN GROSSMAN 2/1/19 Members' Questions Are Still Flowing In Read More
Advocacy at a Glance STEVEN GROSSMAN 2/1/19 Advocacy at a Glance STEVEN GROSSMAN 2/1/19 February 15 Is the New Deadline; Negotiations Begin Read More
Analysis and Commentary STEVEN GROSSMAN 1/26/19 Analysis and Commentary STEVEN GROSSMAN 1/26/19 Shutdown- and BA-Related Q&As Continued Read More
Advocacy at a Glance STEVEN GROSSMAN 1/26/19 Advocacy at a Glance STEVEN GROSSMAN 1/26/19 Possible Temporary End to Shutdown Announced. Read More
STEVEN GROSSMAN 1/18/19 STEVEN GROSSMAN 1/18/19 The Shutdown: Media Snippets and Commentary Read More
Advocacy at a Glance STEVEN GROSSMAN 1/18/19 Advocacy at a Glance STEVEN GROSSMAN 1/18/19 Alliance Works to be a Leading Source of Concern on Shutdown Read More
Advocacy at a Glance STEVEN GROSSMAN 1/11/19 Advocacy at a Glance STEVEN GROSSMAN 1/11/19 Deteriorating Situation at Shut-Down FDA, Despite Commissioner Gottlieb’s Best Efforts Read More
Analysis and Commentary STEVEN GROSSMAN 1/4/19 Analysis and Commentary STEVEN GROSSMAN 1/4/19 Can the Alliance Help to End the Shutdown? No and Yes! Read More
Advocacy at a Glance STEVEN GROSSMAN 1/4/19 Advocacy at a Glance STEVEN GROSSMAN 1/4/19 Soon To Be Released: Alliance’s FDA Shutdown Toolkit Read More
STEVEN GROSSMAN 12/21/18 STEVEN GROSSMAN 12/21/18 What Happens At and After Midnight, Cinderella? Read More
Advocacy at a Glance STEVEN GROSSMAN 12/21/18 Advocacy at a Glance STEVEN GROSSMAN 12/21/18 Barring a Last-Minute Deal, A Partial FDA Shutdown is Likely Read More
Analysis and Commentary STEVEN GROSSMAN 12/15/18 Analysis and Commentary STEVEN GROSSMAN 12/15/18 Is a Shutdown on the Horizon? Read More
Analysis and Commentary STEVEN GROSSMAN 12/10/18 Analysis and Commentary STEVEN GROSSMAN 12/10/18 Critical Issues for the CVM Moving Forward Read More
Advocacy at a Glance STEVEN GROSSMAN 12/10/18 Advocacy at a Glance STEVEN GROSSMAN 12/10/18 Two-Week CR Extension: Can It End the Impasse? Read More
